{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:58:00Z","timestamp":1791932280387,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Danish Victims Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scand J Trauma Resusc Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Few countries recommend glial fibrillary protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a substitute for S100 astroglial calcium-binding protein B (S100B) in early detection of traumatic intracranial lesions in mild TBI (mTBI). This study aims to evaluate the classification agreement between S100B and GFAP\/UCH-L1 in a Scandinavian trauma cohort, to evaluate the performance characteristics of S100B and GFAP\/UCH-L1 for detection of traumatic intracranial lesions, and lastly to evaluate the laboratory performance of the GFAP\/UCH-L1 assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospectively collected data from an unselected cohort of 379 adult trauma patients admitted to a level I trauma center at Aarhus University Hospital, Denmark, were retrospectively analyzed. Analyses were performed in the unselected cohort, in sub-cohort 1 (n\u2009=\u2009218) i.e. patients with any evidence of TBI in their chart as well as\u00a0in sub-cohort 2 (n\u2009=\u2009105) i.e. patients with mTBI defined as Glasgow Coma Scale score\u2009\u2265\u200914, an injury severity score\u2009\u2264\u200915, and blood sampling within 6\u00a0h or 12\u00a0h after trauma. Plasma-samples were used for GFAP\/UCH-L1 measurement and serum-samples were used for S100B measurement. Data analysis involved agreement analysis using Cohens kappa and sensitivity, specificity, positive predictive value and negative predictive value for each biomarker in each of the three cohorts. Lastly, levels of GFAP\/UCH-L1 measured by the Alinity-I platform and the Simoa platform were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Classification agreement between GFAP\/UCH-L1 and S100B was high in all three cohorts, but Cohens kappa improved with increasing proximity to clinical biomarker use and reached an almost perfect identity in sub-cohort 2 (0.70, 95% CI 0.62\u20130.92). S100b had a sensitivity and negative predictive value of 100% in sub-cohort 2, while GFAP\/UCH-L1 reached 100% across all three cohorts. The specificities for both S100B and GFAP\/UCH-L1 were relatively low. Comparing GFAP\/UCH-L1 levels between platforms revealed a low concordance with the Alinity-I platform measuring GFAP levels on average 65% lower and UCH-L1 levels 84% higher than the Simoa platform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, S100B and GFAP\/UCH-L1 had an almost perfect agreement for classification of mTBI patients and comparable diagnostic performances for detecting traumatic intracranial lesions. Our results therefore support GFAP\/UCH-L1 as a feasible alternative to S100B for detecting traumatic intracranial lesions in mTBI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13049-025-01364-9","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:40:41Z","timestamp":1742942441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A head-to-head comparison of S100B and GFAP\/UCH-L1 for detection of traumatic intracranial lesions in a Scandinavian trauma cohort"],"prefix":"10.1186","volume":"33","author":[{"given":"Thea Overgaard","family":"Wichmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad","family":"Babaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Duch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Mylius","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Lesbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars C.","family":"Borris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus V. B.","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/16501960410023732","volume":"36","author":"JD Cassidy","year":"2004","unstructured":"Cassidy JD, Carroll LJ, Peloso PM, Borg J, von Holst H, Holm L, et al. Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med Suppl. 2004;36:28\u201360.","journal-title":"J Rehabil Med Suppl"},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1001\/jama.2015.16316","volume":"314","author":"JS Easter","year":"2015","unstructured":"Easter JS, Haukoos JS, Meehan WP, Novack V, Edlow JA. Will neuroimaging reveal a severe intracranial injury in this adult with minor head trauma? The rational clinical examination systematic review. J Am Med Assoc. 2015;314:2672\u201381.","journal-title":"J Am Med Assoc"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0293558","volume":"19","author":"M Saran","year":"2024","unstructured":"Saran M, Arab-Zozani M, Behzadifar M, Gholami M, Azari S, Bragazzi NL, et al. Overuse of computed tomography for mild head injury: a systematic review and meta-analysis. PLoS ONE. 2024;19:1\u201318.","journal-title":"PLoS ONE"},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.294.12.1519","volume":"294","author":"M Smits","year":"2005","unstructured":"Smits M, Dippel DWJ, De Haan GG, Dekker HM, Vos PE, Kool DR, et al. External validation of the Canadian CT head rule and the New Orleans criteria for CT scanning in patients with minor head injury. JAMA. 2005;294:1519\u201325.","journal-title":"JAMA"},{"key":"1364_CR5","first-page":"483","volume":"38","author":"ER Melnick","year":"2012","unstructured":"Melnick ER, Szlezak CM, Bentley SK, Dziura JD, Kotlyar S, Post LA. CT overuse for mild traumatic brain injury. Jt Comm J Qual Patient Saf. 2012;38:483\u20139.","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"1364_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/QMH.0000000000000151","volume":"26","author":"T Vedin","year":"2017","unstructured":"Vedin T, Edelhamre M, Karlsson M, Bergenheim M, Larsson PA. Management of traumatic brain injury in the emergency department: guideline adherence and patient safety. Qual Manag Health Care. 2017;26:190\u20135.","journal-title":"Qual Manag Health Care"},{"key":"1364_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-50","author":"J Und\u00e9n","year":"2013","unstructured":"Und\u00e9n J, Ingebrigtsen T, Romner B. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med. 2013. https:\/\/doi.org\/10.1186\/1741-7015-11-50.","journal-title":"BMC Med."},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13049-022-01062-w","volume":"31","author":"M Faisal","year":"2023","unstructured":"Faisal M, Vedin T, Edelhamre M, Forberg JL. Diagnostic performance of biomarker S100B and guideline adherence in routine care of mild head trauma. Scand J Trauma Resusc Emerg Med. 2023;31:1\u20138.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/02699052.2020.1725123","volume":"34","author":"CMC Jones","year":"2020","unstructured":"Jones CMC, Harmon C, McCann M, Gunyan H, Bazarian JJ. S100B outperforms clinical decision rules for the identification of intracranial injury on head CT scan after mild traumatic brain injury. Brain Inj. 2020;34:407\u201314. https:\/\/doi.org\/10.1080\/02699052.2020.1725123.","journal-title":"Brain Inj"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.00856","volume":"11","author":"S Kahouadji","year":"2020","unstructured":"Kahouadji S, Salamin P, Praz L, Coiffier J, Frochaux V, Durif J, et al. S100B blood level determination for early management of ski-related mild traumatic brain injury: a pilot Study. Front Neurol. 2020;11:1\u20139.","journal-title":"Front Neurol"},{"key":"1364_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0574-x","author":"R Astrand","year":"2016","unstructured":"Astrand R, Rosenlund C, Und\u00e9n J, Brommeland T, Aarhus M, Sundstr\u00f8m T, et al. Scandinavian guidelines for initial management of minor and moderate head trauma in children. BMC Med. 2016. https:\/\/doi.org\/10.1186\/s12916-016-0574-x.","journal-title":"BMC Med"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/acem.13174","volume":"24","author":"LM Lewis","year":"2017","unstructured":"Lewis LM, Schloemann DT, Papa L, Fucetola RP, Bazarian J, Lindburg M, et al. Utility of serum biomarkers in the diagnosis and stratification of mild traumatic brain injury. Acad Emerg Med. 2017;24:710\u201320.","journal-title":"Acad Emerg Med"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","volume":"73","author":"L Papa","year":"2016","unstructured":"Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, et al. Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol. 2016;73:551\u201360.","journal-title":"JAMA Neurol"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2022.1302","volume":"5","author":"L Papa","year":"2022","unstructured":"Papa L, Ladde JG, O\u2019Brien JF, Thundiyil JG, Tesar J, Leech S, et al. Evaluation of glial and neuronal blood biomarkers compared with clinical decision rules in assessing the need for computed tomography in patients with mild traumatic brain injury. JAMA Netw Open. 2022;5:1\u201313.","journal-title":"JAMA Netw Open"},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjpo-2019-000473","volume":"3","author":"L Papa","year":"2019","unstructured":"Papa L, Zonfrillo MR, Welch RD, Lewis LM, Braga CF, Tan CN, et al. Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: A prospective cohort study. BMJ Paediatr Open. 2019;3:1\u201313.","journal-title":"BMJ Paediatr Open"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/neu.2016.4772","volume":"34","author":"RD Welch","year":"2017","unstructured":"Welch RD, Ellis M, Lewis LM, Ayaz SI, Mika VH, Millis S, et al. Modeling the kinetics of serum glial fibrillary acidic protein, ubiquitin carboxyl-terminal hydrolase-L1, and S100B concentrations in patients with traumatic brain injury. J Neurotrauma. 2017;34:1957\u201371.","journal-title":"J Neurotrauma"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17:782\u20139.","journal-title":"Lancet Neurol"},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.3390\/ijms25084539","volume":"25","author":"C Oris","year":"2024","unstructured":"Oris C, Khatib-Chahidi C, Pereira B, Bailly Defrance V, Bouvier D, Sapin V. Comparison of GFAP and UCH-L1 measurements using two automated immunoassays (i-STAT\u00ae and Alinity\u00ae) for the management of patients with mild traumatic brain injury: preliminary results from a french single-center approach. Int J Mol Sci. 2024;25:4539.","journal-title":"Int J Mol Sci."},{"key":"1364_CR19","unstructured":"U.S. Food & Drug Administration. FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults. [Internet]. U.S. Food Drug Adm. 2018. p. Accessed October 15, 2024. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-first-blood-test-aid-evaluation-concussion-adults"},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms24076602","volume":"24","author":"C Oris","year":"2023","unstructured":"Oris C, Kahouadji S, Durif J, Bouvier D, Sapin V. S100B, actor and biomarker of mild traumatic brain injury. Int J Mol Sci. 2023;24:1\u201318.","journal-title":"Int J Mol Sci"},{"key":"1364_CR21","doi-asserted-by":"publisher","first-page":"101260","DOI":"10.1016\/j.accpm.2023.101260","volume":"42","author":"C Gil-Jardin\u00e9","year":"2023","unstructured":"Gil-Jardin\u00e9 C, Payen JF, Bernard R, Bobbia X, Bouzat P, Catoire P, et al. Management of patients suffering from mild traumatic brain injury 2023. Anaesth Crit Care Pain Med. 2023;42:101260.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/neur.2023.0077","volume":"5","author":"M Keski-Pukkila","year":"2024","unstructured":"Keski-Pukkila M, Karr JE, Posti JP, Berghem K, Kotilainen AK, Blennow K, et al. Preliminary evaluation of the Scandinavian guidelines for initial management of minimal, mild, and moderate head injuries with glial fibrillary acidic protein. Neurotrauma Rep. 2024;5:50\u201360.","journal-title":"Neurotrauma Rep"},{"key":"1364_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-28474-7","volume":"13","author":"M Lesbo","year":"2023","unstructured":"Lesbo M, Hviid CVB, Brink O, Juul S, Borris LC, Hvas AM. Age-dependent thrombin generation predicts 30-day mortality and symptomatic thromboembolism after multiple trauma. Sci Rep. 2023;13:1\u201312. https:\/\/doi.org\/10.1038\/s41598-023-28474-7.","journal-title":"Sci Rep"},{"key":"1364_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-64125-1","volume":"14","author":"IA Kaaber","year":"2024","unstructured":"Kaaber IA, Lesbo M, Wichmann TO, Olsen DA, Rasmussen MM, Brink O, et al. Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury. Sci Rep. 2024;14:1\u201312. https:\/\/doi.org\/10.1038\/s41598-024-64125-1.","journal-title":"Sci Rep."},{"key":"1364_CR25","unstructured":"The Association for the Advancement of Automotive Medicine. Abbreviated Injury Scale (AIS) 2005 \u2013 Update 2008. Barrington, IL: The Association for the Advancement of Automotive Medicine. 2008."},{"key":"1364_CR26","first-page":"S287","volume":"9","author":"L Marshall","year":"1992","unstructured":"Marshall L, Marshall S, Klauber M, Van Berkum CM, Eisenberg H, Jane J, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9:S287-s292.","journal-title":"J Neurotrauma"},{"key":"1364_CR27","unstructured":"Abbott Ireland Diagnostics Division. Alinity i TBI H22974R01. Instructions for use. 2021."},{"key":"1364_CR28","unstructured":"Cobas Elecsys s100, 08817324500V5.0. Kit Incert. Roche Diagnostics GmbH, Sandhofer Strasse, Mannheim, Germany. 2023."},{"issue":"1","key":"1364_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104.","journal-title":"Educ Psychol Meas"},{"key":"1364_CR30","unstructured":"Clinical and laboratory standards institute. EP09. Measurement Procedure comparison and bias estimation using patient samples. 3rd Edition. ISBN. Number 978-1-68440-007-2."},{"key":"1364_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1515\/cclm-2023-1238","volume":"62","author":"C Oris","year":"2024","unstructured":"Oris C, Bouillon-Minois JB, Kahouadji S, Pereira B, Dhaiby G, Defrance VB, et al. S100B vs. \u201cGFAP and UCH-L1\u201d assays in the management of mTBI patients. Clin Chem Lab Med. 2024;62:891\u20139. https:\/\/doi.org\/10.1515\/cclm-2023-1238.","journal-title":"Clin Chem Lab Med"},{"key":"1364_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/neu.2021.0390","volume":"39","author":"H Chen","year":"2022","unstructured":"Chen H, Ding VY, Zhu G, Jiang B, Li Y, Boothroyd D, et al. Association between blood and computed tomographic imaging biomarkers in a cohort of mild traumatic brain injury patients. J Neurotrauma. 2022;39:1329\u201338.","journal-title":"J Neurotrauma"},{"key":"1364_CR33","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1515\/cclm-2018-0471","volume":"56","author":"G Allouchery","year":"2018","unstructured":"Allouchery G, Moustafa F, Roubin J, Pereira B, Schmidt J, Raconnat J, et al. Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients. Clin Chem Lab Med. 2018;56:1897\u2013904.","journal-title":"Clin Chem Lab Med"},{"key":"1364_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-227X-12-13","volume":"12","author":"O Calcagnile","year":"2012","unstructured":"Calcagnile O, Und\u00e9n L, Und\u00e9n J. Clinical validation of S100B use in management of mild head injury. BMC Emerg Med. 2012;12:2\u20137.","journal-title":"BMC Emerg Med"},{"key":"1364_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.annemergmed.2008.01.002","volume":"53","author":"SC Stein","year":"2009","unstructured":"Stein SC, Fabbri A, Servadei F, Glick HA. A critical comparison of clinical decision instruments for computed tomographic scanning in mild closed traumatic brain injury in adolescents and adults. Ann Emerg Med. 2009;53:180\u20138. https:\/\/doi.org\/10.1016\/j.annemergmed.2008.01.002.","journal-title":"Ann Emerg Med"},{"key":"1364_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/neu.2015.4149","volume":"33","author":"RD Welch","year":"2016","unstructured":"Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, et al. Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neurotrauma. 2016;33:203\u201314.","journal-title":"J Neurotrauma"},{"key":"1364_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.01054","volume":"11","author":"NA Huebschmann","year":"2020","unstructured":"Huebschmann NA, Luoto TM, Karr JE, Berghem K, Blennow K, Zetterberg H, et al. Comparing glial fibrillary acidic protein (GFAP) in serum and plasma following mild traumatic brain injury in older adults. Front Neurol. 2020;11:1\u201312.","journal-title":"Front Neurol"},{"key":"1364_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1089\/neu.2015.4121","volume":"38","author":"MC Cnossen","year":"2021","unstructured":"Cnossen MC, Scholten AC, Lingsma HF, Synnot A, Tavender E, Gantner D, et al. Adherence to guidelines in adult patients with traumatic brain injury: a living systematic review. J Neurotrauma. 2021;38:1072\u201385.","journal-title":"J Neurotrauma"},{"key":"1364_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/neur.2021.0078","volume":"3","author":"JB Steinmuller","year":"2022","unstructured":"Steinmuller JB, Lynnerup NM, Steinmetz J, Riis JJ, Doering P. Implementation of the S100 calcium-binding protein b biomarker in a clinical setting: a retrospective study of benefits, safety, and effectiveness. Neurotrauma Rep. 2022;3:447\u201355.","journal-title":"Neurotrauma Rep"},{"key":"1364_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-016-0723-z","volume":"16","author":"O Calcagnile","year":"2016","unstructured":"Calcagnile O, Anell A, Und\u00e9n J. The addition of S100B to guidelines for management of mild head injury is potentially cost saving. BMC Neurol. 2016;16:1\u20137. https:\/\/doi.org\/10.1186\/s12883-016-0723-z.","journal-title":"BMC Neurol"},{"key":"1364_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ebiom.2020.102785","volume":"56","author":"E Czeiter","year":"2020","unstructured":"Czeiter E, Amrein K, Gravesteijn BY, Lecky F, Menon DK, Mondello S, et al. Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020;56:1\u201311.","journal-title":"EBioMedicine"},{"key":"1364_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.wneu.2015.10.066","volume":"87","author":"RSK Takala","year":"2016","unstructured":"Takala RSK, Posti JP, Runtti H, Virginia F. Glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-l1 as outcome predictors in traumatic brain injury. World Neurosurg. 2016;87:8\u201320.","journal-title":"World Neurosurg"},{"key":"1364_CR43","doi-asserted-by":"publisher","first-page":"e1630","DOI":"10.1089\/neu.2023.0491","volume":"41","author":"W Chayoua","year":"2024","unstructured":"Chayoua W, Visser K, de Koning ME, Beishuizen A, Imker R, van der Naalt J, et al. Evaluation of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 using a rapid point of care test for predicting head computed tomography lesions after mild traumatic brain injury in a dutch multi-center cohort. J Neurotrauma. 2024;41:e1630\u201340.","journal-title":"J Neurotrauma"},{"key":"1364_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Wang KKW, Papa L, Sorani MD, Yue JK, Puccio AM, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-l1 and glial fibrillary acidic protein. J Neurotrauma. 2014;31:19\u201325.","journal-title":"J Neurotrauma"},{"key":"1364_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-38804-4","volume":"13","author":"L Papa","year":"2023","unstructured":"Papa L, Brophy GM, Alvarez W, Hirschl R, Cress M, Weber K, et al. Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury. Sci Rep. 2023;13:1\u201313. https:\/\/doi.org\/10.1038\/s41598-023-38804-4.","journal-title":"Sci Rep"},{"key":"1364_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-024-04892-5","volume":"28","author":"S Zylyftari","year":"2024","unstructured":"Zylyftari S, Luger S, Blums K, Barthelmes S, Humm S, Baum H, et al. GFAP point-of-care measurement for prehospital diagnosis of intracranial hemorrhage in acute coma. Crit Care. 2024;28:1\u201311. https:\/\/doi.org\/10.1186\/s13054-024-04892-5.","journal-title":"Crit Care"},{"key":"1364_CR47","doi-asserted-by":"publisher","first-page":"e2431115","DOI":"10.1001\/jamanetworkopen.2024.31115","volume":"7","author":"L Papa","year":"2024","unstructured":"Papa L, McKinley WI, Valadka AB, Newman ZC, Nordgren RK, Pramuka PE, et al. Diagnostic performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 minutes of traumatic brain injury. JAMA Netw Open. 2024;7:e2431115.","journal-title":"JAMA Netw Open"},{"key":"1364_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KKW. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364\u201374.","journal-title":"Trends Neurosci"},{"key":"1364_CR49","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1042\/BCJ20160082","volume":"473","author":"P Bishop","year":"2016","unstructured":"Bishop P, Rocca D, Henley JM. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J. 2016;473:2453\u201362.","journal-title":"Biochem J"},{"key":"1364_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/neu.2023.0322","volume":"41","author":"D Trivedi","year":"2024","unstructured":"Trivedi D, Forssten MP, Cao Y, Ismail AM, Czeiter E, Amrein K, et al. Screening performance of S100 calcium-binding protein B, glial fibrillary acidic protein, and ubiquitin C-terminal hydrolase L1 for intracranial injury within six hours of injury and beyond. J Neurotrauma. 2024;41:349\u201358.","journal-title":"J Neurotrauma"}],"container-title":["Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-025-01364-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13049-025-01364-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-025-01364-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:40:52Z","timestamp":1742942452000},"score":1,"resource":{"primary":{"URL":"https:\/\/sjtrem.biomedcentral.com\/articles\/10.1186\/s13049-025-01364-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1186\/s13049-025-01364-9","relation":{},"ISSN":["1757-7241"],"issn-type":[{"value":"1757-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with all applicable rules and regulations and in accordance with the Declaration of Helsinki. It was approved by the local ethical committee (1-10-72-205-16 & 1-10-72-204-16) and the Data Protection Agency (1-16-02-452-16). Written informed consent was obtained from all patients or their next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors are notified and have given their consent for the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}